Report: FDA may lift hold on Geron's stem cell trial by early 2009

10/20/2008 |

The FDA may lift its hold on Geron's study involving the use of embryonic stem cells in treating spinal cord damage by early 2009, according to a report from The Scientist. The agency placed the trial on hold in May, saying it needed to work out how to regulate therapies based on stem cells.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
Winston-Salem, NC